Bristol Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Bristol Myers Squibb
BMY Stock  USD 55.91  0.81  1.43%   
Bristol Myers' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bristol Myers' valuation are provided below:
Gross Profit
35.1 B
Profit Margin
0.1257
Market Capitalization
115.5 B
Enterprise Value Revenue
3.0255
Revenue
48 B
We have found one hundred twenty available fundamental signals for Bristol Myers Squibb, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Bristol Myers Squibb prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 108.4 B in 2026. Enterprise Value is likely to rise to about 112.4 B in 2026

Bristol Myers Total Revenue

58.32 Billion

Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.6 B, Interest Expense of 2.4 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.95, Dividend Yield of 0.0378 or PTB Ratio of 7.0. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Build AI portfolio with Bristol Stock
Check out the analysis of Bristol Myers Correlation against competitors.

Bristol Myers Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets111.8 B106.5 B67.3 B
Slightly volatile
Short and Long Term Debt Total61.8 B58.9 B26.9 B
Slightly volatile
Other Current Liabilities19.8 B18.9 B9.7 B
Slightly volatile
Total Current Liabilities28.7 B27.3 B15.3 B
Slightly volatile
Total Stockholder Equity15.1 B18.8 B21 B
Slightly volatile
Property Plant And Equipment Net5.3 B9.6 B5.9 B
Slightly volatile
Retained Earnings21.9 B17.1 B26.7 B
Pretty Stable
Cash12.5 B11.9 B7.9 B
Slightly volatile
Non Current Assets Total75.9 B72.2 B45.4 B
Slightly volatile
Non Currrent Assets Other1.5 B2.7 B1.5 B
Slightly volatile
Cash And Short Term Investments6.3 B12.5 B9 B
Slightly volatile
Net Receivables17.4 B16.6 B8.5 B
Slightly volatile
Good Will26.2 B25 B13.7 B
Slightly volatile
Common Stock Shares Outstanding1.6 B1.8 B1.8 B
Pretty Stable
Liabilities And Stockholders Equity111.8 B106.5 B67.3 B
Slightly volatile
Non Current Liabilities Total63.3 B60.3 B30.7 B
Slightly volatile
Inventory1.9 B2.9 B1.9 B
Slightly volatile
Other Current Assets1.7 B2.2 B1.9 B
Pretty Stable
Total Liabilities92 B87.6 B45.9 B
Slightly volatile
Property Plant And Equipment Gross16.1 B15.3 B7.8 B
Slightly volatile
Total Current Assets36 B34.2 B21.9 B
Slightly volatile
Short Term Debt2.7 B2.6 B1.9 B
Slightly volatile
Intangible Assets28.5 B27.2 B19.1 B
Slightly volatile
Accounts Payable4.3 B4.1 B2.6 B
Slightly volatile
Common Stock Total Equity255.5 M335.8 M254.7 M
Slightly volatile
Short Term Investments560.5 M590 M1.5 B
Pretty Stable
Capital Stock260.5 M335.8 M255 M
Slightly volatile
Common Stock260.5 M335.8 M255 M
Slightly volatile
Other Liabilities4.9 B8.5 B6.3 B
Slightly volatile
Other Assets8.9 B8.5 B4 B
Slightly volatile
Long Term Debt57.5 B54.7 B24.5 B
Slightly volatile
Property Plant Equipment6 B9.6 B5.8 B
Slightly volatile
Current Deferred Revenue296.1 M311.6 M1.4 B
Pretty Stable
Retained Earnings Total Equity24.5 B23 B29.2 B
Slightly volatile
Long Term Debt Total57.5 B54.7 B24.8 B
Slightly volatile
Capital Surpluse55.6 B52.9 B23.4 B
Slightly volatile
Deferred Long Term Liabilities2.2 B2.5 B2.2 B
Slightly volatile
Long Term Investments2 B2.3 B2.5 B
Slightly volatile
Non Current Liabilities Other570.3 M600.3 M3.6 B
Very volatile
Deferred Long Term Asset Charges557.2 M586.5 M998.5 M
Slightly volatile
Short and Long Term Debt2.8 B1.8 B4.4 B
Slightly volatile
Cash And Equivalents10.8 B11.9 B8 B
Slightly volatile
Net Invested Capital70.7 B75.9 B47 B
Slightly volatile
Net Working Capital9.1 B6.9 B7 B
Slightly volatile
Capital Lease Obligations1.4 B1.8 B1.1 B
Slightly volatile

Bristol Myers Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization11.6 B11 B4.7 B
Slightly volatile
Selling General Administrative3.6 B5.7 B3.8 B
Slightly volatile
Total Revenue58.3 B55.5 B31 B
Slightly volatile
Gross Profit33.1 B31.5 B19.2 B
Slightly volatile
Other Operating Expenses46.7 B44.4 B24.5 B
Slightly volatile
Operating Income11.7 B11.1 B6.5 B
Slightly volatile
EBITDA6.4 B3.6 B7.4 B
Slightly volatile
Cost Of Revenue25.2 B24 B11.8 B
Slightly volatile
Total Operating Expenses21.5 B20.4 B12.7 B
Slightly volatile
Research Development11.8 B11.2 B6.6 B
Slightly volatile
Selling And Marketing Expenses1.6 B1.7 B4.2 B
Very volatile
Discontinued Operations6 B6.7 B7.3 B
Slightly volatile
Non Recurring2.2 B2.1 B1.7 B
Slightly volatile
Tax Provision473.7 M498.6 M1 B
Very volatile
Interest Income1.8 B1.7 B519.1 M
Slightly volatile
Reconciled Depreciation7.2 B11 B4.5 B
Slightly volatile

Bristol Myers Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow16.8 B16 B8.1 B
Slightly volatile
Begin Period Cash Flow13.9 B13.2 B7.8 B
Slightly volatile
Depreciation11.6 B11 B4.7 B
Slightly volatile
Capital Expenditures859 M1.4 B882.7 M
Slightly volatile
Total Cash From Operating Activities18.3 B17.5 B9 B
Slightly volatile
End Period Cash Flow12.5 B11.9 B7.9 B
Slightly volatile
Stock Based Compensation612.2 M583 M408.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.952.143.7868
Slightly volatile
Dividend Yield0.03780.04880.0323
Slightly volatile
PTB Ratio7.08.075.5041
Pretty Stable
Days Sales Outstanding61.098.191.0072
Slightly volatile
Book Value Per Share5.747.2810.9176
Pretty Stable
Free Cash Flow Yield0.110.12160.0724
Slightly volatile
Operating Cash Flow Per Share7.086.744.3966
Slightly volatile
Stock Based Compensation To Revenue0.00910.00940.0113
Pretty Stable
Capex To Depreciation0.140.150.914
Slightly volatile
PB Ratio7.08.075.5041
Pretty Stable
EV To Sales3.12.94.2023
Slightly volatile
Free Cash Flow Per Share6.56.193.9251
Slightly volatile
ROIC0.20.160.1248
Pretty Stable
Inventory Turnover7.717.355.439
Slightly volatile
Days Of Inventory On Hand48.8651.4387.8421
Slightly volatile
Payables Turnover3.095.214.0355
Slightly volatile
Sales General And Administrative To Revenue0.220.150.1428
Very volatile
Research And Ddevelopement To Revenue0.140.180.2061
Very volatile
Capex To Revenue0.04480.02970.0354
Slightly volatile
Cash Per Share5.064.824.7423
Slightly volatile
POCF Ratio8.258.6817.226
Slightly volatile
Interest Coverage5.425.716.5875
Slightly volatile
Capex To Operating Cash Flow0.08980.09450.1598
Slightly volatile
PFCF Ratio8.989.4623.2319
Slightly volatile
Days Payables Outstanding86.8156.7112
Slightly volatile
EV To Operating Cash Flow23.1411.7719.6002
Slightly volatile
EV To Free Cash Flow22.5412.8325.7712
Slightly volatile
Intangibles To Total Assets0.460.440.3872
Slightly volatile
Current Ratio1.831.441.5697
Slightly volatile
Receivables Turnover5.523.854.1912
Slightly volatile
Shareholders Equity Per Share5.727.2510.8795
Pretty Stable
Debt To Equity2.962.821.1404
Slightly volatile
Capex Per Share0.330.550.4568
Slightly volatile
Revenue Per Share22.5221.4515.3184
Slightly volatile
Interest Debt Per Share24.7823.613.1669
Slightly volatile
Debt To Assets0.520.50.3187
Slightly volatile
Enterprise Value Over EBITDA46.3944.1823.8564
Slightly volatile
Graham Number33.331.7124.5779
Slightly volatile
Short Term Coverage Ratios11.158.548.4713
Slightly volatile
Operating Cycle222177187
Pretty Stable
Price Book Value Ratio7.08.075.5041
Pretty Stable
Days Of Payables Outstanding86.8156.7112
Slightly volatile
Price To Operating Cash Flows Ratio8.258.6817.226
Slightly volatile
Price To Free Cash Flows Ratio8.989.4623.2319
Slightly volatile
Operating Profit Margin0.250.230.2241
Pretty Stable
Company Equity Multiplier5.365.13.0548
Slightly volatile
Long Term Debt To Capitalization0.70.670.4284
Slightly volatile
Total Debt To Capitalization0.720.680.4542
Slightly volatile
Return On Capital Employed0.280.160.1662
Pretty Stable
Debt Equity Ratio2.962.821.1404
Slightly volatile
Ebit Per Revenue0.250.230.2241
Pretty Stable
Quick Ratio1.551.321.4038
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.172.241.8351
Slightly volatile
Net Income Per E B T0.660.960.8002
Slightly volatile
Cash Ratio0.420.390.5433
Pretty Stable
Operating Cash Flow Sales Ratio0.170.280.2569
Slightly volatile
Days Of Inventory Outstanding48.8651.4387.8421
Slightly volatile
Days Of Sales Outstanding61.098.191.0072
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.610.830.8181
Pretty Stable
Cash Flow Coverage Ratios0.320.340.5736
Slightly volatile
Price To Book Ratio7.08.075.5041
Pretty Stable
Fixed Asset Turnover3.275.24.5963
Slightly volatile
Capital Expenditure Coverage Ratio11.510.959.6141
Slightly volatile
Price Cash Flow Ratio8.258.6817.226
Slightly volatile
Enterprise Value Multiple46.3944.1823.8564
Slightly volatile
Debt Ratio0.520.50.3187
Slightly volatile
Cash Flow To Debt Ratio0.320.340.5736
Slightly volatile
Price Sales Ratio2.952.143.7868
Slightly volatile
Asset Turnover0.830.60.5461
Pretty Stable
Gross Profit Margin0.780.650.6774
Slightly volatile
Price Fair Value7.08.075.5041
Pretty Stable

Bristol Myers Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap108.4 B103.2 B101.7 B
Slightly volatile
Enterprise Value112.4 B107.1 B105.9 B
Slightly volatile

Bristol Fundamental Market Drivers

Forward Price Earnings8.9928
Cash And Short Term Investments10.9 B

Bristol Upcoming Events

2nd of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue311.6 M296.1 M
Total Revenue55.5 B58.3 B
Cost Of Revenue24 B25.2 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.15  0.22 
Research And Ddevelopement To Revenue 0.18  0.14 
Capex To Revenue 0.03  0.04 
Revenue Per Share 21.45  22.52 
Ebit Per Revenue 0.23  0.25 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY